PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Systems Biology, Harvard Medical School, Boston, MA, United States of America.\', \'Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States of America.\', \'Stem Cell Program, Boston Children\'s Hospital, Boston, MA, United States of America.\', \'Department of Mechanical Engineering, University of Washington, Seattle, WA, United States of America.\', \'Fractal Therapeutics, Cambridge, MA, United States of America.\', \'Vascular Biology Program, Boston Children\'s Hospital, Boston, MA, United States of America.\', \'Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, United States of America.\', \'Microsoft Research, Redmond, WA, United States of America.\', \'Mark S. Hixon Consulting, LLC, San Diego, CA, United States of America.\', \'Boston University, Boston, MA, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0250780
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33909660
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all